- Home
- DRUG vs DOYU Comparison
DRUG vs DOYU Comparison
Compare DRUG & DOYU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DRUG
- DOYU
- Stock Information
- Founded
- DRUG 2019
- DOYU 2014
- Country
- DRUG United States
- DOYU China
- Employees
- DRUG N/A
- DOYU N/A
- Industry
- DRUG Pharmaceuticals and Biotechnology
- DOYU Computer Software: Programming Data Processing
- Sector
- DRUG Health Care
- DOYU Technology
- Exchange
- DRUG Nasdaq
- DOYU Nasdaq
- Market Cap
- DRUG 199.7M
- DOYU 195.9M
- IPO Year
- DRUG N/A
- DOYU 2019
- Fundamental
- Price
- DRUG $33.63
- DOYU $7.86
- Analyst Decision
- DRUG Strong Buy
- DOYU Hold
- Analyst Count
- DRUG 7
- DOYU 1
- Target Price
- DRUG $83.25
- DOYU $7.00
- AVG Volume (30 Days)
- DRUG 37.4K
- DOYU 78.5K
- Earning Date
- DRUG 08-13-2025
- DOYU 09-11-2025
- Dividend Yield
- DRUG N/A
- DOYU 249.36%
- EPS Growth
- DRUG N/A
- DOYU N/A
- EPS
- DRUG N/A
- DOYU N/A
- Revenue
- DRUG N/A
- DOYU $575,786,186.00
- Revenue This Year
- DRUG N/A
- DOYU N/A
- Revenue Next Year
- DRUG N/A
- DOYU N/A
- P/E Ratio
- DRUG N/A
- DOYU N/A
- Revenue Growth
- DRUG N/A
- DOYU N/A
- 52 Week Low
- DRUG $0.94
- DOYU $5.68
- 52 Week High
- DRUG $79.02
- DOYU $20.17
- Technical
- Relative Strength Index (RSI)
- DRUG 64.40
- DOYU 48.90
- Support Level
- DRUG $31.80
- DOYU $8.45
- Resistance Level
- DRUG $36.50
- DOYU $9.34
- Average True Range (ATR)
- DRUG 2.44
- DOYU 0.51
- MACD
- DRUG 0.79
- DOYU -0.04
- Stochastic Oscillator
- DRUG 70.86
- DOYU 12.13
About DRUG Bright Minds Biosciences Inc.
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The company's drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin.
About DOYU DouYu International Holdings Limited ADS
DouYu International Holdings Ltd is a game-centric live streaming platform in China and a pioneer in the eSports value chain. The company operates its platform on both PC and mobile apps, through which users can enjoy immersive and interactive games and entertainment live streaming. It generates revenues through live streaming and advertisement.